Thiamine Market Report 2026

Thiamine Market Overview

• Thiamine market size has reached to $1.5 billion in 2025 • Expected to grow to $2.3 billion in 2030 at a compound annual growth rate (CAGR) of 8.8% • Growth Driver: Impact Of Increasing Demand For Dietary Supplements On The Thiamine Market • Market Trend: Innovative Thiamine Infusion Products For Vitamin B1 Deficiency Management • Asia-Pacific was the largest region in 2025.

What Is Covered Under Thiamine Market?

Thiamine, or Vitamin B1, is a vital water-soluble nutrient within the B-complex group, essential for carbohydrate metabolism and nerve function. It is crucial for maintaining overall health and proper physiological functions, particularly those related to energy metabolism and neurological health. The main types of thiamine are thiamine mononitrate, thiamine hydrochloride, and thiamine pyrophosphate. Thiamine mononitrate is a synthetic form of thiamine (vitamin B1), which is essential for human health. The various forms involved tablets and capsules, liquid, and powder used in various applications such as food and beverages, pharmaceuticals, animal feed, dietary supplements, and other applications.

What Is The Thiamine Market Growth Forecast?

The thiamine market size is expected to see strong growth in the next few years. It will grow to $2.3 billion in 2030 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to increasing focus on preventive healthcare nutrition, rising demand for clean-label vitamin ingredients, expansion of nutraceutical product development, growing use of vitamins in functional foods, increasing investments in vitamin manufacturing capacity. Major trends in the forecast period include increasing demand for vitamin fortification in foods, rising use of thiamine in dietary supplements, growing application in animal nutrition, expansion of pharmaceutical-grade vitamin production, enhanced focus on bioavailability and stability improvements.

Global Thiamine Market Segmentation

1) By Product Type: Thiamine Mononitrate, Thiamine Hydrochloride, Thiamine Pyrophosphate 2) By Form: Tablets And Capsules, Liquid, Powder 3) By Application: Food And Beverages, Pharmaceuticals, Animal Feed, Dietary Supplements, Other Applications Subsegments: 1) By Thiamine Mononitrate: Powder, Granules, Tablets 2) By Thiamine Hydrochloride: Powder, Injectable Form, Tablets 3) By Thiamine Pyrophosphate: Powder, Injectable Form

What Is The Driver Of The Thiamine Market?

The increasing demand for dietary supplements is expected to boost the growth of the thiamine market going forward. A dietary supplement is a manufactured product intended to supplement a person's diet by taking a pill, capsule, tablet, powder, or liquid. The rising demand for dietary supplements is due to heightened health awareness, a growing preference for preventive healthcare, and an increasing emphasis on immune system support. Thiamine is included in dietary supplements to guarantee sufficient intake of this essential vitamin, which is crucial for vital bodily functions such as energy production, nervous system health, heart function, digestion, stress management, and overall metabolic equilibrium. For instance, in January 2024, according to the Nutrition Integrated, a UK-based business to business service Since January 2022, the availability of clear protein powder products in Europe has increased by 159%, while consumer purchases of clear protein powders in the UK saw a 216% rise in 2023 compared to 2022. Therefore, increasing demand for dietary supplements is driving the growth of the thiamine industry.

Key Players In The Global Thiamine Market

Major companies operating in the thiamine market are BASF SE, Koninklijke DSM N.V., The Nature’s Bounty Co. Ltd., Zhejiang Medicine Co. Ltd., Swanson Health Products Inc., NOW Health Group Inc., Nutricost LLC, Solgar Inc., Tokyo Chemical Industry Co. Ltd., Puritan’s Pride Inc., Aland Nutraceuticals Group, Anhui Tiger Biotech Co. Ltd., Caisson Laboratories Inc., General Nutrition Centers Inc., Huazhong Pharmaceutical Co. Ltd., Xinfa Pharmaceutical Co. Ltd., Jiangxi Tianxin Pharmaceutical Co. Ltd., Acebright Pharmaceuticals Group Co. Ltd., Anhui BBCA Biochemical Co. Ltd., Jiangsu Yibang Pharmaceutical, Nippon Chemical

Global Thiamine Market Trends and Insights

Major companies operating in the thiamine market are focused on developing innovative products, such as vitamin B1 deficiency infusions, to sustain their position in the market. Vitamin B1 deficiency infusion refers to the therapeutic administration of thiamine (Vitamin B1) directly into the bloodstream via intravenous (IV) delivery. For instance, in June 2023, Lupin Limited, an Indian-based pharmaceutical company, launched thiamine hydrochloride injection (USP) in multiple-dose vials containing 200 mg/2 mL (100 mg/mL). This injectable solution offers a direct and efficient alternative for patients with oral absorption challenges, such as gastrointestinal disorders or severe deficiencies needing urgent treatment. It provides healthcare providers with a reliable means to manage and restore vitamin B1 levels, potentially mitigating risks linked to prolonged deficiency.

What Are Latest Mergers And Acquisitions In The Thiamine Market?

In April 2023, Koninklijke DSM NV a Netherlands-based specializing in nutrition, health, and sustainable living, acquired Firmenich International SA for approximately $18.08 billion. Through this acquisition, Koninklijke DSM N.V. aims to create a leading global entity in the nutrition, health, and beauty sectors, known as DSM-Firmenich. Firmenich SA is a Switzerland-based company that provides thiamine (Vitamin B1) in various applications to support health and nutrition.

Regional Outlook

Asia-Pacific was the largest region in the thiamine market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Thiamine Market?

The thiamine market consists of sales of thiamine hydrochloride, thiamine mononitrate, multivitamin supplements, b-complex supplements, and fortified foods. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Thiamine Market Report 2026?

The thiamine market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the thiamine industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.